Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1 receptor agonist medicines such as Wegovy (semaglutide) or Mounjaro (tirzepatide) are designed to be taken once weekly
Increasing the doses of tirzepatide should be guided by a doctor and done in increments of 2.5 mg
At a higher dose (2.4 mg weekly), semaglutide is marketed as Wegovy and licensed specifically for weight management in adults with a BMI of 30 kg/m or 27 kg/m with weight-related comorbidities (with lower thresholds for certain ethnic groups), as an adjunct to diet and exercise
A pilot interview to gauge the comprehensibility and flow of the interview questions was conducted prior to the commencement of formal interviews with this member of the public
In both the FIDELITY analysis and FINEARTS-HF, potassium management strategies, such as pausing treatment when serum potassium levels exceeded 5.5 mmol/L and resuming therapy once levels dropped below 5.0 mmol/L, were effective in preventing hyperkalemia-related adverse events
